CN Patent

CN103153312A — 用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康

Assigned to Slomianny Jan · Expires 2013-06-12 · 13y expired

What this patent protects

本发明涉及用于预防性和治疗性治疗病毒感染的试剂，所述病毒感染特别是来自疱疹病毒家族的那些，所述试剂包含载体物质中的吡罗昔康。

USPTO Abstract

本发明涉及用于预防性和治疗性治疗病毒感染的试剂，所述病毒感染特别是来自疱疹病毒家族的那些，所述试剂包含载体物质中的吡罗昔康。

Drugs covered by this patent

Patent Metadata

Patent number
CN103153312A
Jurisdiction
CN
Classification
—
Expires
2013-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Slomianny Jan
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.